SYKES RICHARD enters PDS BIOTECHNOLOGY CORP with 60.49K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/25/2019ACC: 0001140361-19-005565
60.49K
Baseline shares
100% direct
60.49K
Direct ownership
1 position
26.47K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned60.49K
Total
60.49K direct60.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60.49K | Direct |
| Total | 60.49K | 60.49K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
26.47K
Shares owned
N/A
Exercise price
6.87
Expiration
—
Exercise window
—
Total
Underlying
26.47K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 6.87 | — | — | 26.47K | N/A |
| Total | 26.47K | 0.00 | ||||